Live tape
Top 8, mentions 7d7,207GOOGL1,601 mentions▲ +0.03NKE1,538 mentions▲ +0.03META1,032 mentions▲ +0.05NVDA896 mentions▲ +0.10TSLA606 mentions▲ +0.05MSFT519 mentions▲ +0.04RBA514 mentions▲ +0.05AMZN501 mentions▲ +0.06

Equity · Healthcare

GNPX

NASDAQ

Genprex, Inc.

$7 −12.50% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 10 sessions
$10.0 $0.0 6 Jul 17 Jul

The line runs $0.62 on 6 July through $7 on 17 July, on a scale from $0.0 to $10.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of GNPX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 10 sessions over that window: $0.62 on 6 July 2026 through $7 on 17 July 2026.

Market cap $5.7M
P/E (TTM) 0.0
Avg volume 25.1K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

Filings 4 sets

GNPX reported financials

SEC EDGAR XBRL

GNPX reported net income of −$16.2M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$16.2M 31 Dec 2025 fiscal year
Earnings per share basic −$17.40 31 Dec 2025 fiscal year
Total assets $17.1M 30 Jun 2026 at period end
Total equity $14.8M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

GNPX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-9.40 —
31 Mar 2026 Q1 2026 $-0.64 —
31 Dec 2025 FY 2025 $-17.40 —
30 Sep 2025 Q3 2025 $-5.00 —
30 Jun 2025 Q2 2025 $-185.30 —
31 Mar 2025 Q1 2025 $-12.98 —
31 Dec 2024 FY 2024 $-266.89 —
30 Sep 2024 Q3 2024 $-61.65 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

GNPX fails-to-deliver

SEC CNS data

On 10 Sep 2026, 2,697 shares of GNPX failed to deliver (about $9K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
10 Sep 2026 2,697 $9K 0.329%
09 Sep 2026 2,756 $10K 0.336%
08 Sep 2026 7,687 $27K 0.938%
25 Aug 2026 8 $32 0.001%
19 Aug 2026 9,195 $36K 1.122%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in GNPX

STOCK Act disclosures

The most recent congressional trade disclosed in GNPX is a purchase by Tim Moore (house, NC), dated 18 Dec 2025.

Date Member Type Amount
18 Dec 2025 filed 07 Jan 2026 Tim Moore house · Republican–NC Purchase $1K–$15K
07 Nov 2025 filed 02 Dec 2025 Tim Moore house · Republican–NC Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures